| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > How to Communicate Effectively in Troubled Times |
|
Main Subject - How to Communicate Effectively in Troubled Times
In troubled times – be it war, a shaky economy, or political uncertainty – it's harder than ever to e According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ngage your audiences. There's just so much on everyone's mind. So how do you keep communication going, as it mus ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in , during this time? Communications experts tell us that nonprofits (and other organizations) should expand their lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. communication efforts during war and economic downturn, with an increased focus on fact-driven messages. A recent here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe article in PR Week reports results of a survey of journalists nationwide who almost unanimously urge organization d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro to "communicate factually, frequently, and consistently." "Use this time wisely," say the jo ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc rnalists, "to position yourself." Offhand, I agree with survey findings. It is important to continue t easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi o reach your audiences during this time, especially to reassure them that your organization is still here and sti nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically l working hard to address the issues on which you focus. Remember, people don't stop volunteering, advocating, or and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ giving during tough times. They simply are likely to deliberate more carefully, and more slowly, on where to dire ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi t their resources. I suggest the following: • As always, make sure that your organization has a compell ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ng mission and a unique approach to delivering products, programs, and/or services. Once that's in place, design dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod or refine a potent brand. (Branding is the art of creating a consistent, recognizable, and clear unified voice or cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin personality that conveys your organization's uniqueness, focus, and values.) Once you're confident that your bra tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen nd is on target, stick to it, rather than focusing on short-term needs or concerns. • Review your messag t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel s to ensure that they are relevant in the current environment. Evolve the messages to make sure that they match t ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust e world your audiences are living in today. • Take advantage of the hyper-focused landscape to speak wit y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products a larger voice and define yourself in a somewhat less cluttered marketplace. • Put more online communic . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de tions strategies to work – e-newsletters, web sites with strong content, and more. Online communications us elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ally provide more value for price and, in addition, are more measurable than many other communications strategies tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Alternative Advertising - The Art of Marketing Free Top 7 Reasons to Buy a Franchise instead of starting from Scratch What Your Employees Think and Why Should You Care?
|